Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for ...
Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.
News Medical on MSN
Early tuberculosis treatment reduces sepsis deaths in HIV patients
Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...
Scripps Research scientists designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus.
News-Medical.Net on MSN
New DNA-based vaccine scaffolds boost targeted immune responses to HIV
One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...
Combination antiretroviral therapy (ART) has transformed HIV-1 infection into a chronic condition with near-normal life expectancy. For more than two decades, the standard regimen has been a ...
AZoLifeSciences on MSN
DNA origami vaccine scaffolds sharpen immune targeting against HIV
One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results